Gil Kliman

Gil joined InterWest in 1996. As Managing Partner of the firm and the leader of InterWest’s Healthcare investment team, he invests in a broad array of healthcare opportunities, with a special interest in ophthalmology, digital health, and AI/robotics. Gil pioneered InterWest’s highly successful ophthalmology franchise. He was an early investor in Avedro, Glaukos, LenSx, and IntraLase, all category-creating ophthalmic companies that became standard-of-care for eye surgery around the world.

As a successful digital health investor, Gil built this important franchise for InterWest over the last twenty years through multiple companies. He was the founding institutional investor in Doximity, helping to build it into the leading digital network for physicians, engaging over 80% of U.S. doctors, with over one million users. Gil and InterWest supported Doximity’s June 2021 blockbuster IPO, which subsequently generated the largest investment return in InterWest’s history. Prior to that, he led the Series A of Epocrates, the first mobile application for physicians, serving on the board through its 2011 IPO and continuing as an investor through the 2013 acquisition by athenahealth.